Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multistage nanomedicine engineering to overcome sequential barriers to glioblastoma treatment: a review.

Journal of nanobiotechnology·2026
Same author

Surfaceome Reprogramming of Stemsomes Promotes Lung Cancer Targeting via Potentiated Receptor-Ligand Interactions.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Does tibial sclerosis severity influence bone resorption risk following total knee arthroplasty? : finite element analysis considering implant design and surgical technique.

Bone & joint research·2026
Same author

Acute Macular Hole Formation after Posterior Vitreous Detachment Induction in Epiretinal Membrane Surgery: A Case Report.

Case reports in ophthalmology·2026
Same author

Rank-adaptive covariance testing with applications to genomics and neuroimaging.

Biometrics·2026
Same author

Radiomics-based differentiation of hepatocellular carcinoma and dysplastic nodules using noncontrast abbreviated MRI.

Digital health·2026

Related Experiment Video

Updated: Oct 7, 2025

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

9.6K

Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.

Min Jun Shin1,2, Jun Young Park1,2, Dae Ho Lee3,4

  • 1Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, South Korea.

International Journal of Nanomedicine
|January 10, 2022
PubMed
Summary

Mesenchymal stem cells (MSCs) show promise for regenerative medicine but have limitations. MSC-mimicking nanoencapsulations offer enhanced targeting and drug delivery for immune diseases with improved safety profiles.

Keywords:
autoimmune disease targeting strategyectosomesexosomesliposomesstem cell migrationstem cell mimicking nanoencapsulations

More Related Videos

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

6.7K
Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
10:20

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model

Published on: August 10, 2018

11.4K

Related Experiment Videos

Last Updated: Oct 7, 2025

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

9.6K
Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

6.7K
Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
10:20

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model

Published on: August 10, 2018

11.4K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Immunology

Background:

  • Mesenchymal stem cells (MSCs) possess unique homing abilities, making them promising for targeted therapy in diseases like rheumatoid arthritis (RA).
  • MSCs can modulate inflammation and repair damaged tissues, but their in vivo functionality and migration efficiency are often insufficient.
  • Genetic engineering can enhance MSC therapeutic potential but raises safety concerns regarding oncogenesis and tumor promotion.

Purpose of the Study:

  • To review the mechanisms of MSC homing and the advantages of MSC-mimicking nanoencapsulations.
  • To discuss the potential of genetically engineered MSCs and MSC nanoencapsulations for treating immune-related diseases.
  • To highlight MSC-mimicking nanoencapsulations as a safer alternative for targeted drug delivery.

Main Methods:

  • Review of existing literature on MSC homing mechanisms and therapeutic applications.
  • Analysis of strategies for enhancing MSC targeting and migration via genetic engineering.
  • Exploration of MSC-mimicking nanoencapsulation technologies, including membrane-coated nanoparticles, exosomes, ectosomes, and liposomes.

Main Results:

  • MSC mimicking nanoencapsulations retain MSC targeting capabilities while offering superior drug encapsulation for various therapeutic agents.
  • These nanoencapsulations mitigate safety concerns associated with genetic modification and viral vectors, reducing risks of mutagenesis.
  • Combining genetic engineering with nano-encapsulation strategies presents a promising approach for clinical applications in immune-related diseases.

Conclusions:

  • MSC-mimicking nanoencapsulations represent a significant advancement in targeted drug delivery for immune-related diseases.
  • This strategy overcomes the limitations of traditional MSC therapy and bioengineered MSCs, offering enhanced safety and efficacy.
  • Further development and clinical translation of MSC-mimicking nanoencapsulations hold great promise for regenerative medicine.